BCI-1124

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameBCI-1124
Drug Alias NameBCI-1124
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionColony stimulating factor 1 receptor inhibitorsTyrosine-protein kinase receptor FLT3 inhibitors
TargetsColony stimulating factor 1 receptorTyrosine-protein kinase receptor FLT3
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBCI Pharma
China Registration ClassN/A

Develop Information

Active CompaniesBCI Pharma
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A